These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35224540)

  • 21. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.
    Rosella D; Papi P; Giardino R; Cicalini E; Piccoli L; Pompa G
    J Int Soc Prev Community Dent; 2016; 6(2):97-104. PubMed ID: 27114946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
    Yüce MO; Adalı E; Işık G
    Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw.
    Adachi N; Ayukawa Y; Yasunami N; Furuhashi A; Imai M; Sanda K; Atsuta I; Koyano K
    Sci Rep; 2020 Mar; 10(1):5620. PubMed ID: 32221325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.
    Inada A; Hosohata K; Oyama S; Niinomi I; Mori Y; Yamaguchi Y; Uchida M; Iwanaga K
    Ther Clin Risk Manag; 2019; 15():59-64. PubMed ID: 30636879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
    Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
    BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of double-layer soft tissue closure technology based on pedicled buccal fat pad in repairing maxillary defects after medication-related osteonecrosis of jaw surgery.
    Guo Y; Zhao N; Wang D; Wang Y; Guo C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Jan; 40(1):61-67. PubMed ID: 38596994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model.
    Liu J; Mattheos N; Deng C; Su C; Wang Z; Luo N; Tang H
    J Periodontol; 2021 Jan; 92(1):149-158. PubMed ID: 32281098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis of the jaw associated with ziv-aflibercept.
    Mawardi H; Enzinger P; McCleary N; Manon R; Villa A; Treister N; Woo SB
    J Gastrointest Oncol; 2016 Dec; 7(6):E81-E87. PubMed ID: 28078129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats.
    Castillo EJ; Jiron JM; Croft CS; Freehill DG; Castillo CM; Kura J; Yarrow JF; Bhattacharyya I; Kimmel DB; Aguirre JI
    Front Med (Lausanne); 2023; 10():1179350. PubMed ID: 37404809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology.
    Alsalih A; Dam A; Lindberg P; Truedsson A
    Dent J (Basel); 2021 Jul; 9(8):. PubMed ID: 34435997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
    Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw.
    Wat WZM
    Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study.
    Odet S; Meyer C; Gaudet C; Weber E; Quenot J; Derruau S; Laurence S; Bompy L; Girodon M; Chatelain B; Mauprivez C; Brenet E; Kerdjoudj H; Zwetyenga N; Marchetti P; Hatzfeld AS; Toubeau D; Pouthier F; Lafarge X; Redl H; Fenelon M; Fricain JC; Di Pietro R; Ledouble C; Gualdi T; Parmentier AL; Louvrier A; Gindraux F
    Front Bioeng Biotechnol; 2022; 10():936074. PubMed ID: 35935507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.
    Pan J; Liu JY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):245-254. PubMed ID: 34041871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
    Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):871-877. PubMed ID: 33791853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Narrative Review of Osteonecrosis of the Jaw: What a Clinician Should Know.
    Sharma S; Shankar R; Ravi Kiran BS; Breh R; Sarangi S; Kumar Upadhyay A
    Cureus; 2023 Dec; 15(12):e51183. PubMed ID: 38283469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.